Garry Milman

1.5k total citations
27 papers, 1.3k citations indexed

About

Garry Milman is a scholar working on Pharmacology, Toxicology and Pathology and Forensic Medicine. According to data from OpenAlex, Garry Milman has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 20 papers in Toxicology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Garry Milman's work include Cannabis and Cannabinoid Research (24 papers), Forensic Toxicology and Drug Analysis (20 papers) and Alcohol Consumption and Health Effects (8 papers). Garry Milman is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Forensic Toxicology and Drug Analysis (20 papers) and Alcohol Consumption and Health Effects (8 papers). Garry Milman collaborates with scholars based in United States, Israel and Spain. Garry Milman's co-authors include Allan J. Barnes, Marilyn A. Huestis, David A. Gorelick, Dayong Lee, David M. Schwope, Raphael Mechoulam, Robert S. Goodwin, Marilyn A. Huestis, Ross H. Lowe and Nathalie A. Desrosiers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Garry Milman

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Milman United States 22 961 572 257 224 188 27 1.3k
Randy J. Krebsbach United States 16 1.2k 1.3× 197 0.3× 236 0.9× 390 1.7× 187 1.0× 18 1.5k
B R Martin United States 17 1.0k 1.1× 327 0.6× 137 0.5× 636 2.8× 64 0.3× 28 1.2k
Kent‐Olov Jonsson Sweden 10 625 0.7× 74 0.1× 125 0.5× 211 0.9× 118 0.6× 10 743
Jessica P. Alexander United States 6 602 0.6× 107 0.2× 89 0.3× 206 0.9× 109 0.6× 6 934
Dolores R. Brine United States 16 634 0.7× 306 0.5× 158 0.6× 295 1.3× 69 0.4× 27 1.1k
Lisa K. Brents United States 17 892 0.9× 673 1.2× 163 0.6× 468 2.1× 27 0.1× 26 1.2k
Natalya M. Kogan Israel 15 650 0.7× 104 0.2× 49 0.2× 202 0.9× 115 0.6× 27 974
Gilmour Morrison United Kingdom 10 1.0k 1.1× 81 0.1× 83 0.3× 297 1.3× 170 0.9× 16 1.2k
M Widman Sweden 14 520 0.5× 178 0.3× 131 0.5× 227 1.0× 62 0.3× 31 739
Mariateresa Cipriano Sweden 16 867 0.9× 56 0.1× 59 0.2× 261 1.2× 166 0.9× 25 1.3k

Countries citing papers authored by Garry Milman

Since Specialization
Citations

This map shows the geographic impact of Garry Milman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Milman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Milman more than expected).

Fields of papers citing papers by Garry Milman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Milman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Milman. The network helps show where Garry Milman may publish in the future.

Co-authorship network of co-authors of Garry Milman

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Milman. A scholar is included among the top collaborators of Garry Milman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Milman. Garry Milman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Dayong, Mateus M. Bergamaschi, Garry Milman, et al.. (2015). Plasma Cannabinoid Pharmacokinetics After Controlled Smoking andAd libitumCannabis Smoking in Chronic Frequent Users. Journal of Analytical Toxicology. 39(8). 580–587. 36 indexed citations
2.
Desrosiers, Nathalie A., Garry Milman, Damodara Rao Mendu, et al.. (2014). Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices. Analytical and Bioanalytical Chemistry. 406(17). 4117–4128. 32 indexed citations
3.
Anizan, Sébastien, Mateus M. Bergamaschi, Allan J. Barnes, et al.. (2014). Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Drug Testing and Analysis. 7(2). 114–120. 18 indexed citations
4.
Huestis, Marilyn A., Garry Milman, Damodara Rao Mendu, et al.. (2013). Evaluation of the on-site Draeger DrugTest 5000 in occasional and chronic frequent smokers following controlled cannabis smoking. 2 indexed citations
5.
Lee, Dayong, Ryan G. Vandrey, Garry Milman, et al.. (2013). Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Analytical and Bioanalytical Chemistry. 405(23). 7269–7279. 21 indexed citations
6.
Milman, Garry, Mateus M. Bergamaschi, Dayong Lee, et al.. (2013). Plasma Cannabinoid Concentrations During Dronabinol Pharmacotherapy for Cannabis Dependence. Therapeutic Drug Monitoring. 36(2). 218–224. 15 indexed citations
7.
Anizan, Sébastien, Garry Milman, Nathalie A. Desrosiers, et al.. (2013). Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and Bioanalytical Chemistry. 405(26). 8451–8461. 50 indexed citations
8.
Milman, Garry, David M. Schwope, David A. Gorelick, & Marilyn A. Huestis. (2012). Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clinica Chimica Acta. 413(7-8). 765–770. 48 indexed citations
9.
Lee, Dayong, Erin L Karschner, Garry Milman, et al.. (2012). Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?. Drug and Alcohol Dependence. 130(1-3). 68–76. 26 indexed citations
10.
Lee, Dayong, David M. Schwope, Garry Milman, et al.. (2012). Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis. Clinical Chemistry. 58(4). 748–756. 56 indexed citations
11.
Milman, Garry, Allan J. Barnes, David M. Schwope, et al.. (2011). Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Analytical and Bioanalytical Chemistry. 401(2). 599–607. 25 indexed citations
12.
Lee, Dayong, Garry Milman, Allan J. Barnes, et al.. (2011). Oral Fluid Cannabinoids in Chronic, Daily Cannabis Smokers during Sustained, Monitored Abstinence. Clinical Chemistry. 57(8). 1127–1136. 65 indexed citations
13.
Milman, Garry, Allan J. Barnes, Ross H. Lowe, & Marilyn A. Huestis. (2010). Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. Journal of Chromatography A. 1217(9). 1513–1521. 86 indexed citations
14.
Smoum, Reem, Bo Tan, Garry Milman, et al.. (2010). Oleoyl Serine, an Endogenous Regulator of Skeletal Mass. Bone. 46. S81–S81. 1 indexed citations
15.
Barnes, Allan J., Richie H. Lowe, Garry Milman, et al.. (2009). Urinary MDMA, MDA, HMMA, and HMA Excretion Following Controlled MDMA Administration to Humans. Journal of Analytical Toxicology. 33(8). 439–446. 44 indexed citations
16.
Patinkin, Deborah, Garry Milman, Aviva Breuer, Ester Fride, & Raphael Mechoulam. (2008). Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. European Journal of Pharmacology. 595(1-3). 1–6. 33 indexed citations
17.
Godlewski, Grzegorz, László Offertáler, Douglas Osei‐Hyiaman, et al.. (2008). The Endogenous Brain Constituent N-Arachidonoyl l-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels. Journal of Pharmacology and Experimental Therapeutics. 328(1). 351–361. 34 indexed citations
18.
Aguado, Tania, Arkaitz Carracedo, Boris Julien, et al.. (2007). Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis. Journal of Biological Chemistry. 282(9). 6854–6862. 104 indexed citations
19.
Bermúdez‐Silva, Francisco J., Juan Suárez, Elena Baixerás, et al.. (2007). Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia. 51(3). 476–487. 161 indexed citations
20.
Milman, Garry, Yehoshua Maor, Saleh Abu‐Lafi, et al.. (2006). N-arachidonoyll-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proceedings of the National Academy of Sciences. 103(7). 2428–2433. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randy J. Krebsbach Breakdown of academic impact, for papers by B R Martin Breakdown of academic impact, for papers by Kent‐Olov Jonsson Breakdown of academic impact, for papers by Jessica P. Alexander Breakdown of academic impact, for papers by Dolores R. Brine Breakdown of academic impact, for papers by Lisa K. Brents Breakdown of academic impact, for papers by Natalya M. Kogan Breakdown of academic impact, for papers by Gilmour Morrison Breakdown of academic impact, for papers by M Widman Breakdown of academic impact, for papers by Mariateresa Cipriano
Rankless by CCL
2026